NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS: CLZNY), Polished.com, Inc. (NYSEAmerican : POL), Singularity Future Technology Ltd. (NASDAQ: SGLY) and EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT). Our investigations address whether these companies have violated federal securities laws and/or engaged in other illegal business practices. For more information on each case, see the link provided.

Clariant AG (OTCMKTS:CLZNY)

On February 14, 2022, Swiss chemicals manufacturer Clariant AG announced that it will delay the release of its fourth quarter 2021 and full year 2021 financial results due to an ongoing internal investigation into potential accounting fraud.

Clariant AG is investigating internal whistleblower complaints known to the company since September 2021 relating to accounting issues aimed at increasing results to meet targets.

As a result of this news, Clariant AG ADR shares fell by more than 14% in intraday trading on February 14, 2022.

For more information on the Clariant investigation, go to: https://bespc.com/cases/CLZNY

Polished.com, Inc. (NYSEAmerican: POL)

In July 2020, Polished (then known as 1847 Goedeker Inc.) completed its initial public offering (“IPO”) and sold shares at a price of $9.00 per share.

Then, on August 15, 2022, after the market close, Polished announced on its Form 12b-25 filed with the SEC that as a result it was unable to file its Form 10-Q for the second quarter of its fiscal year 2022 ended August 30, 2022. June 2022 ended to be filed in a timely manner The Board’s Audit Committee recently opened “an independent investigation regarding certain allegations made by certain former employees in connection with the Company’s operations.” In addition, the company announced that “[t]The investigation is ongoing and the Audit Committee continues to work diligently with independent counsel and counsel to complete the investigation.